✦ LIBER ✦

Successful treatment of HIV-1-related, zidovudine resistant, thrombocytopenia with didanosine

✍ Scribed by Nasti, G.; Errante, D.; Tirelli, U.

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 35 KB
Volume: 55
Category: Article
ISSN: 0361-8609
DOI: 10.1002/(sici)1096-8652(199706)55:2<118::aid-ajh13>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent selection pressure with zid

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations

✍ Izopet, J.; Sailler, L.; Sandres, K.; Pasquier, C.; Bonnet, E.; Aquilina, C.; Pu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

The development of mutations conferring drug resistance was investigated in 49 antiretroviralnaive asymptomatic HIV-1 subjects with CD4 + cell counts of 250-500/mm 3 given intermittent (6-week courses, 6 weeks apart) or continuous treatment with zidovudine (AZT) plus zalcitabine (ddC) over 54 weeks.

Saquinavir delays the emergence of zidov

Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy

✍ Andreoni, M.; Sarmati, L.; Nicastri, E.; Ventura, L.; Ercoli, L.; Parisi, S. G.; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

During a randomized double-blind study to assess the antiviral activity of saquinavir (SQV) alone or in combination with zidovudine (ZDV), the emergence of phenotypic resistance was evaluated in 44 patients treated with SQV (13 subjects), ZDV (14 subjects), and SQV plus ZDV (17 subjects). A signific